Huber needles find wide application in blood transfusions, chemotherapy, drug delivery, parenteral nutrition, surgical procedures such as angioplasty and diagnostic procedures such as contrast CT scans. Therefore wide application areas predominantly drive the Huber needles market globally. Growing prevalence of cancer across the globe increases the rate of chemotherapy administration, indicating higher demand for Huber needles. As per the International Agency for Research on Cancer (IARC), cancer is expected to increase to 21.7 million by 2030. With increasing prevalence of infectious diseases across the globe, number of blood transfusions have also risen. The rate of blood donations have also increased with growing awareness on need for blood and blood products, and rising willingness of people to donate. The World Health Organization (WHO) states that around 112.5 million blood donations were carried out globally, as per 2017 review.
Advancement in diagnostic techniques has also contributed to the lucrativeness of Huber needles segment. For instance, contrast CT scans require injecting of special intravenous contrast dye. The number of such diagnostic tests keeps on increasing with growing prevalence of cancer and chronic diseases, thus contributing to the overall market growth. Manufacturers are continuously carrying out research activities in developing advanced products catering to patient's safety requirements. Introduction by the Food and Drug Administration (FDA) of anti-coring test for Huber needles ensures patient safety thus further raising its demand.
Of the product types available in the market such as, straight and curved Huber needles, curved Huber needles are said to highlight potential market growth during the forecast period. They are utilised to deliver parenteral nutrition, medications and in certain chemotherapy regimens. Curved Huber needles can be left in injected place for few days, therefore without requiring periodic change as seen in straight Huber needles.
North America is likely to emerge as dominant regional market owing to rise in prevalence of cancer, chronic diseases and blood donations. Additionally, growth in diagnosis rate, developed healthcare infrastructure and provision of reimbursement for needles contribute to the overall market growth. However, rising cost of Huber needles, and the risk of coring and contamination leading to infections could have a negative impact on the overall market growth.
Global market outreach and key players:
The Huber needles market comprises a competitive pool of many market leaders. Huber needles are globally available with presence of multiple manufacturers across geographies. Key players having vast market outreach are AngioDynamics, Inc., B. Braun Medical Inc., Baxter International Inc., C.R. Bard, Inc., Exel International, Inc., Medsurg, NIPRO Medical Corporations, Novo Nordsik, Smiths Medical, Inc., Thiebaud S.A.S., Vygon S.A. And Other Notable Players.
Historical & Forecast Period
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Huber Needles market are as follows:
- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report:
Micro and macro environment factors that are currently influencing the Huber Needles market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Segmentation
Product
- Straight Huber Needles
- Curved Huber Needles
Application
- Transfusion of Blood
- Application for Cancer
- Parental Nutrition
- Others
End user
- Hospitals
- Clinics
- Ambulatory surgical centers
- Others
Region Segment (2021-2031; US$ Million)
- North America
- U.S.
- Canada
- Rest of North America
- UK and European Union
- UK
- Germany
- Spain
- Italy
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- Africa
- Rest of Middle East and Africa
Key questions answered in this report:
- What are the key micro and macro environmental factors that are impacting the growth of Huber Needles market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2031.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Huber Needles market?
- Which is the largest regional market for Huber Needles market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Huber Needles market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Huber Needles market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Huber Needles Market
- 2.2. Global Huber Needles Market, By Product, 2022 (US$ Million)
- 2.3. Global Huber Needles Market, By Application, 2022 (US$ Million)
- 2.4. Global Huber Needles Market, By End user, 2022 (US$ Million)
- 2.5. Global Huber Needles Market, By Geography, 2022 (US$ Million)
- 2.6. Attractive Investment Proposition by Geography, 2022
3. Huber Needles Market: Competitive Analysis
- 3.1. Market Positioning of Key Huber Needles Market Vendors
- 3.2. Strategies Adopted by Huber Needles Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2022 Versus 2031
4. Huber Needles Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Huber Needles Market Value, 2021 - 2031, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
5. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2022 Versus 2031
- 5.3. Market Segmentation
- 5.3.1. Straight Huber Needles
- 5.3.2. Curved Huber Needles
6. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2022 Versus 2031
- 6.3. Market Segmentation
- 6.3.1. Transfusion of Blood
- 6.3.2. Application for Cancer
- 6.3.3. Parental Nutrition
- 6.3.4. Others
7. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 7.1. Market Overview
- 7.2. Growth & Revenue Analysis: 2022 Versus 2031
- 7.3. Market Segmentation
- 7.3.1. Hospitals
- 7.3.2. Clinics
- 7.3.3. Ambulatory surgical centers
- 7.3.4. Others
8. North America Huber Needles Market, 2021-2031, USD (Million)
- 8.1. Market Overview
- 8.2. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 8.3. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 8.4. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 8.5.Huber Needles Market: By Region, 2021-2031, USD (Million)
- 8.5.1.North America
- 8.5.1.1. U.S.
- 8.5.1.1.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 8.5.1.1.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 8.5.1.1.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 8.5.1.2. Canada
- 8.5.1.2.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 8.5.1.2.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 8.5.1.2.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 8.5.1.3. Rest of North America
- 8.5.1.3.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 8.5.1.3.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 8.5.1.3.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
9. UK and European Union Huber Needles Market, 2021-2031, USD (Million)
- 9.1. Market Overview
- 9.2. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 9.3. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 9.4. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 9.5.Huber Needles Market: By Region, 2021-2031, USD (Million)
- 9.5.1.UK and European Union
- 9.5.1.1. UK
- 9.5.1.1.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 9.5.1.1.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 9.5.1.1.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 9.5.1.2. Germany
- 9.5.1.2.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 9.5.1.2.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 9.5.1.2.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 9.5.1.3. Spain
- 9.5.1.3.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 9.5.1.3.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 9.5.1.3.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 9.5.1.4. Italy
- 9.5.1.4.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 9.5.1.4.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 9.5.1.4.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 9.5.1.5. France
- 9.5.1.5.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 9.5.1.5.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 9.5.1.5.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 9.5.1.6. Rest of Europe
- 9.5.1.6.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 9.5.1.6.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 9.5.1.6.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
10. Asia Pacific Huber Needles Market, 2021-2031, USD (Million)
- 10.1. Market Overview
- 10.2. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 10.3. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 10.4. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 10.5.Huber Needles Market: By Region, 2021-2031, USD (Million)
- 10.5.1.Asia Pacific
- 10.5.1.1. China
- 10.5.1.1.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 10.5.1.1.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 10.5.1.1.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 10.5.1.2. Japan
- 10.5.1.2.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 10.5.1.2.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 10.5.1.2.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 10.5.1.3. India
- 10.5.1.3.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 10.5.1.3.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 10.5.1.3.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 10.5.1.4. Australia
- 10.5.1.4.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 10.5.1.4.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 10.5.1.4.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 10.5.1.5. South Korea
- 10.5.1.5.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 10.5.1.5.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 10.5.1.5.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 10.5.1.6. Rest of Asia Pacific
- 10.5.1.6.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 10.5.1.6.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 10.5.1.6.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
11. Latin America Huber Needles Market, 2021-2031, USD (Million)
- 11.1. Market Overview
- 11.2. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 11.3. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 11.4. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 11.5.Huber Needles Market: By Region, 2021-2031, USD (Million)
- 11.5.1.Latin America
- 11.5.1.1. Brazil
- 11.5.1.1.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 11.5.1.1.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 11.5.1.1.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 11.5.1.2. Mexico
- 11.5.1.2.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 11.5.1.2.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 11.5.1.2.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 11.5.1.3. Rest of Latin America
- 11.5.1.3.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 11.5.1.3.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 11.5.1.3.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
12. Middle East and Africa Huber Needles Market, 2021-2031, USD (Million)
- 12.1. Market Overview
- 12.2. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 12.3. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 12.4. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 12.5.Huber Needles Market: By Region, 2021-2031, USD (Million)
- 12.5.1.Middle East and Africa
- 12.5.1.1. GCC
- 12.5.1.1.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 12.5.1.1.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 12.5.1.1.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 12.5.1.2. Africa
- 12.5.1.2.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 12.5.1.2.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 12.5.1.2.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
- 12.5.1.3. Rest of Middle East and Africa
- 12.5.1.3.1. Huber Needles Market: By Product, 2021-2031, USD (Million)
- 12.5.1.3.1. Huber Needles Market: By Application, 2021-2031, USD (Million)
- 12.5.1.3.1. Huber Needles Market: By End user, 2021-2031, USD (Million)
13. Company Profile
- 13.1. AngioDynamics, Inc.
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Portfolio
- 13.1.4. Strategic Initiatives
- 13.2. B. Braun Medical Inc.
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Portfolio
- 13.2.4. Strategic Initiatives
- 13.3. Baxter International Inc.
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Portfolio
- 13.3.4. Strategic Initiatives
- 13.4. C.R. Bard, Inc.
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Portfolio
- 13.4.4. Strategic Initiatives
- 13.5. Exel International, Inc.
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Portfolio
- 13.5.4. Strategic Initiatives
- 13.6. Medsurg
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Portfolio
- 13.6.4. Strategic Initiatives
- 13.7. NIPRO Medical Corporations
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Portfolio
- 13.7.4. Strategic Initiatives
- 13.8. Novo Nordsik
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Portfolio
- 13.8.4. Strategic Initiatives
- 13.9. Smiths Medical, Inc.
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Portfolio
- 13.9.4. Strategic Initiatives
- 13.10. Thiebaud S.A.S.
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Portfolio
- 13.10.4. Strategic Initiatives
- 13.11. Vygon S.A.
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Portfolio
- 13.11.4. Strategic Initiatives
- 13.12. Other Notable Players
- 13.12.1. Company Overview
- 13.12.2. Financial Performance
- 13.12.3. Product Portfolio
- 13.12.4. Strategic Initiatives